Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

Clinical trial NCT01553279 · COMPLETED

Trial details

NCT number: NCT01553279
Sponsor: MCM Vaccines B.V.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neisseria Meningitidis Bacterial Infections Virus Diseases

Start date: 2012-03-30
Primary completion: 2013-09-27
Enrollment: 284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.